About Vintor Erythropoietin Alfa Injection 6000IU
Discover a sizzling and premier solution for anemia management-Vintor Erythropoietin Alfa Injection 6000IU. This hot deal combines customizable treatment with potent efficacy from recombinant glycoprotein technology. Each pivotal dose is delivered in a sterile, single-use prefilled syringe, designed for subcutaneous or IV administration. Packed with Erythropoietin Alfa 6000 IU, it offers therapeutic protein replacement for patients with chronic kidney disease-related anemia. With its neutral pH, odorless and clear texture, and temperature-stable formulation, Vintor sets a new standard for safety and effectiveness. Exported from India, it is the premier choice for healthcare needs worldwide.
Therapeutic Efficacy & Distinguished Features
Vintor Erythropoietin Alfa Injection 6000IU is primarily used to treat anemia due to chronic kidney disease. Its primary competitive advantages are the potent, consistent enzymatic activity and reliable sterile formulation. Special features include a single-pack, single-use prefilled syringe for easy and safe administration, customizable for individual patient needs, and manufactured using recombinant glycoprotein technology. With a shelf life of 36 months and a neutral pH, it stands out in premier therapeutic management.
Reliable Supply & Hassle-Free Packaging
Stock is ready for swift dispatch across the main domestic market, ensuring prompt shipment for urgent medical requirements. Vintor Erythropoietin Alfa Injection 6000IU is packaged securely in a single-use prefilled syringe, maintaining sterility and integrity during transport. Our robust supply ability guarantees consistent availability, and every shipment is handled with care to preserve product quality, supporting both exporters and suppliers throughout India.
FAQ's of Vintor Erythropoietin Alfa Injection 6000IU:
Q: How should Vintor Erythropoietin Alfa Injection 6000IU be administered?
A: Vintor Erythropoietin Alfa Injection 6000IU should be administered by subcutaneous or intravenous injection, as directed by a healthcare professional.
Q: What is the primary therapeutic benefit of this injection?
A: The primary benefit is the stimulation of erythropoiesis, which helps treat anemia caused by chronic kidney disease through recombinant protein replacement.
Q: When is it recommended to use Vintor Erythropoietin Alfa Injection 6000IU?
A: This injection is recommended for patients diagnosed with anemia due to chronic kidney disease who require protein replacement therapy.
Q: Where should the product be stored before use?
A: Vintor Erythropoietin Alfa Injection 6000IU should be stored in a refrigerator at 2-8C to maintain potency and sterility.
Q: What are the packaging details for shipment and supply?
A: Each unit is packed in a secure, single-use prefilled syringe and dispatched in single packs to ensure easy handling and preserve product quality during shipment.
Q: How is Vintor Erythropoietin Alfa Injection 6000IU supplied in the domestic market?
A: The product is supplied promptly with stock ready for distribution, ensuring timely delivery throughout the domestic market of India.